Global Preclinical Imaging Market Size, Share, Competitive Landscape and Forecast Trend Analysis – By Product (CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents and Others), By Modality (Standalone and Integrated), By Application (Drug Discovery and Development, Disease Research and Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs) and Diagnostic Centers) & Region – Global Forecasts 2024 - 2034 .
- PUBLISHED ON
- 2024-12-26
- NO OF PAGES
- 310
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Preclinical Imaging market growth is predicted to develop at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2034, when global Preclinical Imaging market forecast revenue is projected to reach USD 8.36 Billion in 2034, based on an average growth pattern. The global Preclinical Imaging Market Size is estimated to reach a value of USD 4.19 Billion in 2024.
SOURCE: We Market Research
The global
preclinical imaging market report focuses on advanced imaging technologies used
in preclinical research to study diseases, develop drugs, and evaluate
biological processes in animal models. It plays a critical role in
translational research by bridging basic science and clinical applications.
Preclinical imaging involves the visualization of biological processes at the
molecular level in animal models, typically in vivo, to gain insights into
human diseases. The Global Preclinical Imaging Market analysis refers to the
sector of the healthcare and biotechnology industry focused on the development,
manufacturing, and application of imaging technologies and systems used in
preclinical research. Preclinical imaging involves the visualization of
biological processes at the molecular, cellular, tissue, or whole-animal level,
primarily in non-human subjects, to advance drug discovery, development, and
translational research.
Global Preclinical Imaging Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 4.19 Billion |
|
Market
Forecast in 2034 |
USD 8.36 Billion |
|
CAGR % 2024-2034 |
5.1% |
|
Base
Year |
2023 |
|
Historic Data |
2019-2023 |
|
Forecast
Period |
2024-2034 |
|
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
|
Segments
Covered |
By Product,
By Modality, By Application, By End-Use and By Region |
|
Regional Scope |
North America,
Europe, APAC, Latin America and Middle East and Africa |
|
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Market Dynamics & Restraints
Global Preclinical Imaging Market Opportunity:
We Market
Research: Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into global Preclinical Imaging market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Preclinical Imaging Market Segmentation
The Global Preclinical
Imaging Market industry analysis is segmented into by Product, by Modality, by
Application, by End-User and by Region. By Product the market is segmented into
CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical
Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents and Others. In
terms of Modality the market is bifurcated into Standalone and Integrated. Based
on Application Preclinical Imaging Market is divided into Drug Discovery and
Development, Disease Research and Others. In terms of End-User, Global
Preclinical Imaging Market is categorized into Pharmaceutical and Biotechnology
Companies, Academic and Research Institutes, Contract Research Organizations
(CROs) and Diagnostic Centers.
Market- By Product Analysis
By Product, the Preclinical Imaging market share is categories into CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents and Others. PET/SPECT Imaging segments holds the largest share in Global Preclinical Imaging market trends, accounting for approximately 30%. PET and SPECT imaging are crucial for molecular imaging and are widely used in oncology, neurology, and drug development, making them some of the highest contributors to the market. These nuclear medicine techniques continue to play a significant role, particularly in oncology and neurology research. PET and SPECT imaging allow for functional imaging, providing insights into metabolic processes in vivo, which is vital for drug discovery.
The
following segments are part of an in-depth analysis of the global Preclinical
Imaging market:
|
Market Segments |
|
|
By Product |
·
CT Imaging ·
MRI Imaging ·
PET/SPECT Imaging ·
Multi-modal Imaging ·
Optical Imaging ·
Ultrasound Imaging ·
Photoacoustic Imaging ·
Reagents ·
Others |
|
By Application |
·
Drug Discovery and Development ·
Disease Research ·
Others |
|
By Modality |
·
Standalone ·
Integrated |
|
By End-use |
·
Pharmaceutical and Biotechnology Companies ·
Academic and Research Institutes ·
Contract Research Organizations (CROs) ·
Diagnostic Centers |
Preclinical Imaging Market Industry: Regional Analysis
North America Market Forecast
North America holds the largest share of the global Preclinical Imaging market, accounting for approximately 45% of the market. Preclinical Imaging Market revenue in North America is expected to reach 1.88 Billion in 2024. North America, particularly the United States, dominates the preclinical imaging market due to its advanced healthcare infrastructure, high investment in pharmaceutical R&D, and a large number of research institutions and contract research organizations (CROs). The region is also home to major players in the imaging equipment market.
Europe Market Statistics
Europe holds a
significant share, driven by robust pharmaceutical and biotechnology sectors in
countries like Germany, the UK, and France. The region also benefits from
strong academic and research initiatives supporting preclinical studies,
alongside a favorable regulatory environment.
Asia Pacific Market Forecasts
The Asia Pacific
region is experiencing rapid growth due to the increasing investment in life
sciences and healthcare infrastructure in countries like China, Japan, India,
and South Korea. With an expanding pharmaceutical market and growing research
collaborations, the region is expected to continue its upward trajectory in the
preclinical imaging market.
Middle East & Africa Market Statistics
The MEA region
has a smaller share in the global market but is gradually growing, driven by
improving healthcare facilities, increased research funding, and growing
interest in preclinical studies. Investments in healthcare infrastructure are
expected to support growth in the coming years.
Latin America Market Statistics
Latin America
holds a modest share of the market, with countries like Brazil and Mexico
leading the way in preclinical research investments. The region is seeing
gradual improvements in healthcare systems and research capabilities, leading
to moderate market growth.
Key Market Players
The Global Preclinical Imaging Market is highly competitive, with a mix of established companies and emerging players. The market is characterized by technological innovation, strategic partnerships, acquisitions, and the growing demand for advanced imaging solutions in preclinical research. Many companies are forming strategic partnerships with academic institutions, pharmaceutical companies, and contract research organizations (CROs) to enhance their product offerings and expand market reach. Major companies in the global Preclinical Imaging market report include PerkinElmer, Bruker, and Siemens Healthineers.
The Global Preclinical
Imaging Market is dominated by a few
large companies, such as
·
PerkinElmer, Inc.
·
Bruker Corporation
·
Siemens Healthineers AG
·
FUJIFILM VisualSonics, Inc.
·
MR Solutions Ltd.
·
Mediso Ltd.
·
TriFoil Imaging
·
MILabs B.V.
·
LI-COR Biosciences
·
Aspect Imaging
·
Thermo Fisher Scientific, Inc.
·
Agilent Technologies, Inc.
·
Bio-Rad Laboratories, Inc.
·
ZEISS Group
·
VisualSonics (FUJIFILM Holdings
Corporation)
·
Shenzhen Mindray Bio-Medical
Electronics Co., Ltd.
·
TomoWave Laboratories, Inc.
·
Kubtec Scientific
·
Others
1.
Global
Preclinical Imaging Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Preclinical Imaging
Market Scope and Market Estimation
1.2.1. Global Preclinical Imaging Overall
Market Size (US$ Bn), Market CAGR (%), Market forecast (2024 - 2034)
1.2.2. Global Preclinical Imaging
Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Product of Global Preclinical
Imaging Market
1.3.2. Application of Global Preclinical
Imaging Market
1.3.3. Modality of Global Preclinical Imaging
Market
1.3.4. End-User of Global Preclinical
Imaging Market
1.3.5. Region of Global Preclinical
Imaging Market
2.
Executive Summary
2.1. Demand Side Trends
2.2. Key Market Trends
2.3. Market Demand (US$ Bn) Analysis
2019 – 2023 and Forecast, 2024 – 2034
2.4. Demand and Opportunity
Assessment
2.5. Demand Supply Scenario
2.6. Market Dynamics
2.6.1. Drivers
2.6.2. Limitations
2.6.3. Opportunities
2.6.4. Impact Analysis of Drivers and
Restraints
2.7. Pricing Trends Analysis
2.8. Overview of Technology Developments
2.9. Porter’s Five Forces Analysis
2.9.1. Bargaining Power of Suppliers
2.9.2. Bargaining Power of Buyers
2.9.3. Threat of Substitutes
2.9.4. Threat of New Entrants
2.9.5. Competitive Rivalry
2.10. PEST Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technology Factors
2.11. Value Chain / Ecosystem Analysis
2.12. Key Regulation
3.
Global Preclinical Imaging
Market Estimates & Historical Trend
Analysis (2019 - 2023)
4.
Global Preclinical Imaging
Market Estimates & Forecast Trend
Analysis, by Product
4.1. Global Preclinical Imaging
Market Revenue (US$ Bn) Estimates and Forecasts, by Product, 2019 - 2034
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Others
5.
Global Preclinical Imaging
Market Estimates & Forecast Trend
Analysis, by Application
5.1. Global Preclinical Imaging
Market Revenue (US$ Bn) Estimates and Forecasts, by Application, 2019 - 2034
5.1.1.Drug
Discovery and Development
5.1.2.Disease
Research
5.1.3.Others
6.
Global Preclinical Imaging
Market Estimates & Forecast Trend
Analysis, by Modality
6.1. Global Preclinical Imaging
Market Revenue (US$ Bn) Estimates and Forecasts, by Modality, 2019 - 2034
6.1.1.Standalone
6.1.2.Integrated
7.
Global Preclinical Imaging
Market Estimates & Forecast Trend
Analysis, by End-user
7.1. Global Preclinical Imaging
Market Revenue (US$ Bn) Estimates and Forecasts, by End-user, 2019 - 2034
7.1.1.Pharmaceutical
and Biotechnology Companies
7.1.2.Academic
and Research Institutes
7.1.3.Contract
Research Organizations (CROs)
7.1.4.Diagnostic
Centers
8.
Global Preclinical Imaging
Market Estimates & Forecast Trend
Analysis, by Region
8.1. Global Preclinical Imaging
Market Revenue (US$ Bn) Estimates and Forecasts, by Region, 2019 - 2034
8.1.1. North America
8.1.2. Eastern Europe
8.1.3. Western Europe
8.1.4. Asia Pacific
8.1.5. Middle East & Africa
8.1.6. Latin America
9.
North
America Preclinical Imaging Market: Estimates & Forecast Trend Analysis
9.1.
North
America Preclinical Imaging Market Assessments & Key Findings
9.1.1. North America Preclinical
Imaging Market Introduction
9.1.2. North America Preclinical
Imaging Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
9.1.2.1. By Product
9.1.2.2. By Application
9.1.2.3. By Modality
9.1.2.4. By End-user
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.2. Canada
9.1.2.5.3. Mexico
10. Western Europe Preclinical
Imaging Market: Estimates &
Forecast Trend Analysis
10.1. Western Europe Preclinical
Imaging Market Assessments & Key Findings
10.1.1. Western Europe Preclinical
Imaging Market Introduction
10.1.2. Western Europe Preclinical
Imaging Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
10.1.2.1. By Product
10.1.2.2. By Application
10.1.2.3. By Modality
10.1.2.4. By End-user
10.1.2.5. By Country
10.1.2.5.1.
Germany
10.1.2.5.2.
Italy
10.1.2.5.3.
U.K.
10.1.2.5.4.
France
10.1.2.5.5.
Spain
10.1.2.5.6.
Benelux
10.1.2.5.7.
Nordics
10.1.2.5.8. Rest
of W. Europe
11. Eastern Europe Preclinical
Imaging Market: Estimates &
Forecast Trend Analysis
11.1. Eastern Europe Preclinical
Imaging Market Assessments & Key Findings
11.1.1. Eastern Europe Preclinical
Imaging Market Introduction
11.1.2. Eastern Europe Preclinical
Imaging Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
11.1.2.1. By Product
11.1.2.2. By Application
11.1.2.3. By Modality
11.1.2.4. By End-user
11.1.2.5. By Country
11.1.2.5.1.
Russia
11.1.2.5.2.
Hungary
11.1.2.5.3.
Poland
11.1.2.5.4.
Balkan & Baltics
11.1.2.5.5. Rest of E. Europe
12. Asia Pacific Preclinical
Imaging Market: Estimates &
Forecast Trend Analysis
12.1. Asia Pacific Market Assessments
& Key Findings
12.1.1. Asia Pacific Preclinical Imaging
Market Introduction
12.1.2. Asia Pacific Preclinical Imaging
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
12.1.2.1. By Product
12.1.2.2. By Application
12.1.2.3. By Modality
12.1.2.4. By End-user
12.1.2.5. By Country
12.1.2.5.1. China
12.1.2.5.2. Japan
12.1.2.5.3. India
12.1.2.5.4. Australia & New Zealand
12.1.2.5.5. South Korea
12.1.2.5.6. ASEAN
12.1.2.5.7. Rest of Asia Pacific
13. Middle East & Africa Preclinical
Imaging Market: Estimates &
Forecast Trend Analysis
13.1. Middle East & Africa Market
Assessments & Key Findings
13.1.1. Middle
East & Africa Preclinical
Imaging Market Introduction
13.1.2. Middle
East & Africa Preclinical
Imaging Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
13.1.2.1. By Product
13.1.2.2. By Application
13.1.2.3. By Modality
13.1.2.4. By End-user
13.1.2.5. By Country
13.1.2.5.1. UAE
13.1.2.5.2. Saudi
Arabia
13.1.2.5.3. Turkey
13.1.2.5.4. South
Africa
13.1.2.5.5. Rest of
MEA
14. Latin America
Preclinical Imaging Market: Estimates
& Forecast Trend Analysis
14.1. Latin America Market Assessments
& Key Findings
14.1.1. Latin America Preclinical
Imaging Market Introduction
14.1.2. Latin America Preclinical
Imaging Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
14.1.2.1. By Product
14.1.2.2. By Application
14.1.2.3. By Modality
14.1.2.4. By End-user
14.1.2.5. By Country
14.1.2.5.1. Brazil
14.1.2.5.2. Argentina
14.1.2.5.3. Colombia
14.1.2.5.4. Rest of
LATAM
15. Country Wise Market:
Introduction
16. Competition Landscape
16.1. Global Preclinical Imaging
Market Product Mapping
16.2. Global Preclinical Imaging Market
Concentration Analysis, by Leading Players / Innovators / Emerging Players /
New Entrants
16.3. Global Preclinical Imaging
Market Tier Structure Analysis
16.4. Global Preclinical Imaging
Market Concentration & Company Market Shares (%) Analysis, 2023
17. Company Profiles
17.1. PerkinElmer, Inc.
17.1.1. Company Overview & Key Stats
17.1.2. Financial Performance & KPIs
17.1.3. Product Portfolio
17.1.4. SWOT Analysis
17.1.5. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
17.2. Bruker Corporation
17.3. Siemens
Healthineers AG
17.4. FUJIFILM
VisualSonics, Inc.
17.5. MR Solutions Ltd.
17.6. Mediso Ltd.
17.7. TriFoil Imaging
17.8. MILabs B.V.
17.9. LI-COR Biosciences
17.10. Aspect Imaging
17.11. Thermo Fisher
Scientific, Inc.
17.12. Agilent
Technologies, Inc.
17.13. Bio-Rad
Laboratories, Inc.
17.14. ZEISS Group
17.15. VisualSonics
(FUJIFILM Holdings Corporation)
17.16. Shenzhen Mindray
Bio-Medical Electronics Co., Ltd.
17.17. TomoWave
Laboratories, Inc.
17.18. Kubtec Scientific
17.19. Others
18. Research
Methodology
18.1. External Transportations /
Databases
18.2. Internal Proprietary Database
18.3. Primary Research
18.4. Secondary Research
18.5. Assumptions
18.6. Limitations
18.7. Report FAQs
19. Research
Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Preclinical Imaging Market in 2024?
Preclinical Imaging Market was valued at USD 4.19 Billion in 2024.
What is the growth rate for the Preclinical Imaging Market?
Preclinical Imaging Market size will increase at approximate CAGR of 5.1% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the market are PerkinElmer, Inc., Bruker Corporation, Siemens Healthineers AG, FUJIFILM VisualSonics, Inc., MR Solutions Ltd., Mediso Ltd., TriFoil Imaging, MILabs B.V., LI-COR Biosciences, Aspect Imaging, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc. and others.
Which region dominates the Preclinical Imaging Market?
North America dominates the market with an active share of 45%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI